HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].

Abstract
A 78-year-old male patient had esophageal carcinoma with multiple liver metastases. Chemoradiotherapy was performed. The chemotherapy consisted of protracted infusion of 5-fluorouracil (5-FU), combined with infusion of nedaplatin (NDP). Radiation of the mediastinum was administered concomitantly with chemotherapy. The patient showed a complete response (CR) of the primary lesion and a partial response (PR) of the liver metastasis for 11 months. Since liver metastasis recurred after initial treatment, chemotherapy consisting of NDP infusion combined with vindesine sulfate (VDS) infusion was performed. The patient again showed PR. Grade 3 leukocytopenia occurred during treatment, but there were no major toxicities such as thrombocytopenia, nausea, renal dysfunction or esophagitis. Survival time was one year and 7 months. In conclusion, concurrent chemoradiotherapy including NDP is effective and safe for patients with esophageal carcinoma accompanied by multiple liver metastasis. This nonsurgical approach may be an option for standard care in such cases.
AuthorsK Kaneko, H Ito, T Ito, K Konishi, T Kurahashi, T Yamamoto, J Eguchi, T Kitahara, K Mitamura
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 28 Issue 6 Pg. 831-4 (Jun 2001) ISSN: 0385-0684 [Print] Japan
PMID11432353 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Organoplatinum Compounds
  • nedaplatin
  • Fluorouracil
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Esophageal Neoplasms (drug therapy, pathology, radiotherapy, therapy)
  • Fluorouracil (administration & dosage)
  • Humans
  • Liver Neoplasms (drug therapy, radiotherapy, secondary, therapy)
  • Male
  • Organoplatinum Compounds (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: